Dube Eric M — SEC insider filings

SEC reporting owner CIK 1763494. 36 insider filings on record with FilingPulse; latest filed 2026-10-19.

Transaction summary — filings shown

Covers all 36 filings on record, filed 2020-09-22 to 2026-10-19. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.

By issuer — same filings

Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.

IssuerRole (as filed)FilingsPurchases (P)Sales (S)Other legs
Travere Therapeutics, Inc. (TVTX)CHIEF EXECUTIVE OFFICER, Director34—54 legs · 1,385,581 sh · $59,635,47150
Reneo Pharmaceuticals, Inc. (RPHM)Director2——2

Insider filings — Dube Eric M

FiledFormIssuerReported transactionsSource
2026-10-194Travere Therapeutics, Inc. (TVTX)Option exercise (M): 43,735 @ $26.88 · Option exercise (M): 200,000 @ $8.93 · Sale (S): 128,065 @ $52.97 · Sale (S): 37,270 @ $54.20 · Sale (S): 78,400 @ $55.02 · Option exercise (M): 43,735 (derivative) @ $0 · +1 moreEDGAR
2026-09-174Travere Therapeutics, Inc. (TVTX)Option exercise (M): 95,666 @ $23.34 · Sale (S): 63,498 @ $61.99 · Sale (S): 28,796 @ $62.66 · Sale (S): 3,102 @ $63.64 · Sale (S): 270 @ $65.31 · Option exercise (M): 195,841 @ $23.34 · +8 moreEDGAR
2026-05-064Travere Therapeutics, Inc. (TVTX)Option exercise (M): 22,500 @ $0 · Sale (S): 22,500 @ $43.95 · Grant/award (A): 45,000 (derivative) @ $0 · Option exercise (M): 22,500 (derivative) @ $0EDGAR
2026-04-154Travere Therapeutics, Inc. (TVTX)Grant/award (A): 64,000 @ $0 · Sale (S): 56,815 @ $41.01 · Sale (S): 7,165 @ $41.75 · Sale (S): 20 @ $42.66EDGAR
2026-04-024Travere Therapeutics, Inc. (TVTX)Option exercise (M): 60,000 @ $15.46 · Sale (S): 34,902 @ $30.55 · Sale (S): 25,098 @ $31.46 · Option exercise (M): 60,000 (derivative) @ $0EDGAR
2026-02-244Travere Therapeutics, Inc. (TVTX)Option exercise (M): 60,000 @ $15.46 · Sale (S): 60,000 @ $30.10 · Option exercise (M): 60,000 (derivative) @ $0EDGAR
2026-02-034Travere Therapeutics, Inc. (TVTX)Grant/award (A): 113,800 @ $0 · Sale (S): 66,452 @ $32.06 · Sale (S): 33,635 @ $32.70 · Grant/award (A): 303,600 (derivative) @ $0EDGAR
2026-01-274Travere Therapeutics, Inc. (TVTX)Option exercise (M): 8,135 @ $15.46 · Sale (S): 8,135 @ $30.01 · Option exercise (M): 51,865 @ $15.46 · Sale (S): 51,865 @ $30.10 · Option exercise (M): 8,135 (derivative) @ $0 · Option exercise (M): 51,865 (derivative) @ $0EDGAR
2025-10-304Travere Therapeutics, Inc. (TVTX)Option exercise (M): 92,872 @ $15.46 · Sale (S): 92,872 @ $30.38 · Option exercise (M): 27,128 @ $15.46 · Sale (S): 27,128 @ $30.12 · Option exercise (M): 92,872 (derivative) @ $0 · Option exercise (M): 27,128 (derivative) @ $0EDGAR
2025-05-054Travere Therapeutics, Inc. (TVTX)Option exercise (M): 18,924 · Sale (S): 18,924 @ $21.05 · Option exercise (M): 18,924 (derivative) @ $0EDGAR
2025-02-124Travere Therapeutics, Inc. (TVTX)Sale (S): 11,375 @ $24.04EDGAR
2025-02-044Travere Therapeutics, Inc. (TVTX)Grant/award (A): 130,000 @ $0 · Sale (S): 50,691 @ $20.21 · Grant/award (A): 260,000 (derivative) @ $0EDGAR
2025-01-234Travere Therapeutics, Inc. (TVTX)Sale (S): 10,736 @ $19.46EDGAR
2024-09-094Travere Therapeutics, Inc. (TVTX)Grant/award (A): 32,500 @ $0 · Sale (S): 21,125 @ $11.52EDGAR
2024-02-024Travere Therapeutics, Inc. (TVTX)Grant/award (A): 135,000 @ $0 · Sale (S): 9,106 @ $8.53 · Sale (S): 10,016 @ $8.86 · Grant/award (A): 360,000 (derivative) @ $0EDGAR
2024-01-254Travere Therapeutics, Inc. (TVTX)Sale (S): 7,873 @ $8.96EDGAR
2023-09-054Travere Therapeutics, Inc. (TVTX)Grant/award (A): 9,900 @ $0 · Sale (S): 4,455 @ $14.71EDGAR
2023-06-084Reneo Pharmaceuticals, Inc. (RPHM)Grant/award (A): 17,500 (derivative) @ $0EDGAR
2023-02-024Travere Therapeutics, Inc. (TVTX)Grant/award (A): 97,500 @ $0 · Sale (S): 8,196 @ $22.25 · Grant/award (A): 260,000 (derivative) @ $0 · Grant/award (A): 32,500 (derivative) @ $0EDGAR
2023-01-264Travere Therapeutics, Inc. (TVTX)Sale (S): 6,442 @ $21.50EDGAR
2023-01-064Travere Therapeutics, Inc. (TVTX)Sale (S): 5,625 @ $20.75EDGAR
2022-06-034Reneo Pharmaceuticals, Inc. (RPHM)Grant/award (A): 17,500 (derivative) @ $0EDGAR
2022-02-114Travere Therapeutics, Inc. (TVTX)Sale (S): 4,832 @ $27.84EDGAR
2022-02-024Travere Therapeutics, Inc. (TVTX)Grant/award (A): 37,848 @ $0 · Sale (S): 4,813 @ $27.40 · Grant/award (A): 169,552 (derivative) @ $0 · Grant/award (A): 37,848 (derivative) @ $0EDGAR
2022-01-264Travere Therapeutics, Inc. (TVTX)Sale (S): 7,873 @ $24.98EDGAR
2022-01-064Travere Therapeutics, Inc. (TVTX)Sale (S): 4,832 @ $30.43 · Sale (S): 10,361 @ $29.84 · Sale (S): 2,139 @ $30.48EDGAR
2021-08-174Travere Therapeutics, Inc. (TVTX)Grant/award (A): 17,500 @ $0 · Sale (S): 7,836 @ $17.12EDGAR
2021-06-034Travere Therapeutics, Inc. (TVTX)Sale (S): 4,782 @ $14.89 · Sale (S): 4,780 @ $14.35EDGAR
2021-02-094Travere Therapeutics, Inc. (TVTX)Sale (S): 4,813 @ $31.41 · Sale (S): 4,813 @ $31.58EDGAR
2021-02-054Travere Therapeutics, Inc. (TVTX)Grant/award (A): 17,500 @ $0EDGAR
2021-02-034Travere Therapeutics, Inc. (TVTX)Sale (S): 2,406 @ $28.91EDGAR
2021-02-024Travere Therapeutics, Inc. (TVTX)Grant/award (A): 15,000 @ $0 · Sale (S): 6,328 @ $29.60 · Sale (S): 2,406 @ $30.75EDGAR
2021-01-284/ATravere Therapeutics, Inc. (TVTX)Grant/award (A): 212,660 (derivative) @ $0EDGAR
2021-01-254Travere Therapeutics, Inc. (TVTX)Grant/award (A): 57,260 @ $0 · Grant/award (A): 212,600 (derivative) @ $0EDGAR
2021-01-074Travere Therapeutics, Inc. (TVTX)Sale (S): 3,438 @ $26.65 · Sale (S): 3,438 @ $27.01EDGAR
2020-09-224Retrophin, Inc. (RTRX)Grant/award (A): 25,000 @ $0 · Grant/award (A): 3,000 @ $0 · Sale (S): 9,240 @ $19.28 · Sale (S): 1,565 @ $19.29EDGAR

FilingPulse's Form 4 archive currently extends back to 2020-09-21 and is expanding backward through EDGAR history; Forms 3 and 5 are covered live-forward since 2026-09-23 (no 3/5 history). Earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.

Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1763494 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. Get a free API key → · API docs